Fangmei Luo

Statistics

Publications

Citations

130

H-Index

Active since

2019

Affiliations

Xiangya Hospital Central South University(Current)

Central South University

Hunan Children's Hospital

Fangmei Luo is an author at Xiangya Hospital Central South University specializing in pulmonary hypertension, hypoxia-induced pulmonary hypertension, and cellular responses to hypoxia.

Publications per year

2019–2023

Publications

Magnolol Attenuates Right Ventricular Hypertrophy and Fibrosis in Hypoxia-Induced Pulmonary Arterial Hypertensive Rats Through Inhibition of the JAK2/STAT3 Signaling Pathway

Minyi Fu, Fangmei Luo, E-Li Wang et al. · Frontiers in Pharmacology · 2021 · 35 citations · Full text

Medicine, Cardiology, Pharmacology +14

Cerebellin-2 promotes endothelial-mesenchymal transition in hypoxic pulmonary hypertension rats by activating NF-κB/HIF-1α/Twist1 pathway

E-Li Wang, Jie-Jie Zhang, Fangmei Luo et al. · Life Sciences · 2023 · 26 citations

Life Sciences, Cell Biology, Molecular Biology +15

Down-regulation of the mitochondrial fusion protein Opa1/Mfn2 promotes cardiomyocyte hypertrophy in Su5416/hypoxia-induced pulmonary hypertension rats

Fangmei Luo, Minyi Fu, Ting Wang et al. · Archives of Biochemistry and Biophysics · 2023 · 22 citations · Full text

Life Sciences, Cardiology, Physiology +12

Coordination between NADPH oxidase and vascular peroxidase 1 promotes dysfunctions of endothelial progenitor cells in hypoxia-induced pulmonary hypertensive rats

E-Li Wang, Miaomiao Jia, Fangmei Luo et al. · European Journal of Pharmacology · 2019 · 17 citations

Life Sciences, Cell Biology, Physiology +17

Magnolol alleviates hypoxia-induced pulmonary vascular remodeling through inhibition of phenotypic transformation in pulmonary arterial smooth muscle cells

Xinghua Xiao, Fangmei Luo, E.-Li Wang et al. · Biomedicine & Pharmacotherapy · 2022 · 15 citations · Full text

Medicine, Pharmacology, Physiology +17

1–5 of 6